• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.默克尔细胞癌:基于人口结构变化的美国当前发病率和预计增长。
J Am Acad Dermatol. 2018 Mar;78(3):457-463.e2. doi: 10.1016/j.jaad.2017.10.028. Epub 2017 Nov 2.
2
Merkel cell carcinoma: changing incidence trends.默克尔细胞癌:发病率变化趋势
J Surg Oncol. 2005 Jan 1;89(1):1-4. doi: 10.1002/jso.20167.
3
Epidemiology of primary Merkel cell carcinoma in the United States.美国原发性默克尔细胞癌的流行病学。
J Am Acad Dermatol. 2003 Nov;49(5):832-41. doi: 10.1016/s0190-9622(03)02108-x.
4
Merkel cell carcinoma and melanoma: etiological similarities and differences.默克尔细胞癌与黑色素瘤:病因学上的异同
Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):153-8.
5
Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.澳大利亚昆士兰州 1993-2010 年 Merkel 细胞癌的发病率和生存率。
JAMA Dermatol. 2014 Aug;150(8):864-72. doi: 10.1001/jamadermatol.2014.124.
6
Incidence of Merkel cell carcinoma in Olmsted County, Minnesota: a population-based study.明尼苏达州奥尔姆斯特德县默克尔细胞癌的发病率:一项基于人群的研究。
Int J Dermatol. 2016 Jan;55(1):e11-5. doi: 10.1111/ijd.12812. Epub 2015 Jul 31.
7
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Merkel 细胞癌:发病率、死亡率和其他癌症风险。
J Natl Cancer Inst. 2010 Jun 2;102(11):793-801. doi: 10.1093/jnci/djq120. Epub 2010 Apr 27.
8
Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States.评估美国 Merkel 细胞癌发病率的年龄、时期和出生队列效应及趋势。
JAMA Dermatol. 2021 Jan 1;157(1):59-65. doi: 10.1001/jamadermatol.2020.4102.
9
Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.默克尔细胞癌的流行病学。1985 年至 2013 年法国东北部的一项基于人群的研究。
Int J Cancer. 2019 Feb 15;144(4):741-745. doi: 10.1002/ijc.31860. Epub 2018 Oct 4.
10
Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016.澳大利亚维多利亚州 1986 年至 2016 年间 Merkel 细胞癌发病率的趋势。
Australas J Dermatol. 2020 Feb;61(1):e34-e38. doi: 10.1111/ajd.13131. Epub 2019 Aug 19.

引用本文的文献

1
Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection.用于默克尔细胞癌复发检测的多瘤病毒抗体
JAMA Dermatol. 2025 Sep 10. doi: 10.1001/jamadermatol.2025.3155.
2
Merkel cell carcinoma presenting as a nasal dorsum mass: A case report and literature review.以鼻背肿物为表现的默克尔细胞癌:1例病例报告及文献复习
World J Clin Cases. 2025 Aug 26;13(24):105244. doi: 10.12998/wjcc.v13.i24.105244.
3
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).瑞替凡利单抗用于复发性局部晚期或转移性默克尔细胞癌患者的II期研究(POD1UM-201)。
J Immunother Cancer. 2025 Aug 11;13(8):e012478. doi: 10.1136/jitc-2025-012478.
4
Type of pre-existing chronic conditions and their associations with Merkel cell carcinoma (MCC) treatment: Prediction and interpretation using machine learning methods.既往慢性疾病的类型及其与默克尔细胞癌(MCC)治疗的关联:使用机器学习方法进行预测和解读
PLoS One. 2025 Jul 18;20(7):e0327964. doi: 10.1371/journal.pone.0327964. eCollection 2025.
5
Optimizing radiation therapy for merkel cell carcinoma: evaluating prognostic factors and treatment outcomes.优化默克尔细胞癌的放射治疗:评估预后因素和治疗结果。
Int J Clin Oncol. 2025 Jul 17. doi: 10.1007/s10147-025-02838-7.
6
Rare occurrence of penoscrotal basal cell carcinoma: Clinicopathologic findings from a single institution cohort and comprehensive literature review.阴茎阴囊基底细胞癌的罕见病例:单机构队列的临床病理结果及文献综述
Virchows Arch. 2025 Jul 16. doi: 10.1007/s00428-025-04188-1.
7
Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases.默克尔细胞癌:聚焦于骨和骨髓转移的最新综述
Cancers (Basel). 2025 Jul 6;17(13):2253. doi: 10.3390/cancers17132253.
8
Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma.自发肿瘤消退和免疫治疗反应显示默克尔细胞癌中存在克隆性T细胞扩增。
NPJ Precis Oncol. 2025 Jul 1;9(1):212. doi: 10.1038/s41698-025-00987-6.
9
The Use of Intrinsic Disorder and Phosphorylation by Oncogenic Viral Proteins to Dysregulate the Host Cell Cycle Through Interaction with pRb.致癌病毒蛋白利用内在无序和磷酸化通过与pRb相互作用来失调宿主细胞周期。
Viruses. 2025 Jun 10;17(6):835. doi: 10.3390/v17060835.
10
Poorly Differentiated Neuroendocrine Tumors of the Pancreas: A Comparative Analysis of Primary Versus Secondary Tumors-A Literature Review.胰腺低分化神经内分泌肿瘤:原发性与继发性肿瘤的比较分析——文献综述
Biomedicines. 2025 Jun 11;13(6):1437. doi: 10.3390/biomedicines13061437.

本文引用的文献

1
Colorectal cancer statistics, 2017.结直肠癌统计数据,2017 年。
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
2
A population-based cohort study on the association of dermatologist density and Merkel cell carcinoma survival.一项基于人群的队列研究,探讨皮肤科医生密度与默克尔细胞癌生存率之间的关联。
J Am Acad Dermatol. 2017 Mar;76(3):570-572. doi: 10.1016/j.jaad.2016.10.043.
3
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.阿维鲁单抗治疗化疗难治性转移性默克尔细胞癌患者:一项多中心、单组、开放标签的2期试验。
Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1.
4
Epidemiological trends in Merkel cell carcinoma in southern France: a registry-based study.法国南部默克尔细胞癌的流行病学趋势:一项基于登记处的研究。
Br J Dermatol. 2017 May;176(5):1379-1381. doi: 10.1111/bjd.14950. Epub 2017 Mar 10.
5
Merkel cell carcinoma incidence is increasing in Sweden.瑞典的默克尔细胞癌发病率正在上升。
J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1708-1713. doi: 10.1111/jdv.13698. Epub 2016 May 2.
6
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.帕博利珠单抗用于晚期默克尔细胞癌的PD-1阻断治疗。
N Engl J Med. 2016 Jun 30;374(26):2542-52. doi: 10.1056/NEJMoa1603702. Epub 2016 Apr 19.
7
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.细胞角蛋白20阴性默克尔细胞癌的下一代测序揭示了紫外线特征性突变以及TP53和RB1的反复失活。
Mod Pathol. 2016 Mar;29(3):240-8. doi: 10.1038/modpathol.2015.154. Epub 2016 Jan 8.
8
Survival with nonmelanoma skin cancer in Germany.德国非黑素瘤皮肤癌的存活率。
Br J Dermatol. 2016 Apr;174(4):778-85. doi: 10.1111/bjd.14352. Epub 2016 Mar 22.
9
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.MCPyV阳性和MCPyV阴性默克尔细胞癌的突变图谱及其对免疫治疗的意义。
Oncotarget. 2016 Jan 19;7(3):3403-15. doi: 10.18632/oncotarget.6494.
10
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.UV 相关突变是 MCV 阴性 Merkel 细胞癌发病机制的基础。
Cancer Res. 2015 Dec 15;75(24):5228-34. doi: 10.1158/0008-5472.CAN-15-1877. Epub 2015 Dec 1.

默克尔细胞癌:基于人口结构变化的美国当前发病率和预计增长。

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Divisions of Medical Oncology and Dermatology, Department of Medicine, University of Washington, Seattle, Washington.

Divisions of Medical Oncology and Dermatology, Department of Medicine, University of Washington, Seattle, Washington.

出版信息

J Am Acad Dermatol. 2018 Mar;78(3):457-463.e2. doi: 10.1016/j.jaad.2017.10.028. Epub 2017 Nov 2.

DOI:10.1016/j.jaad.2017.10.028
PMID:29102486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5815902/
Abstract

BACKGROUND

Merkel cell carcinoma (MCC) incidence rates are rising and strongly age-associated, relevant for an aging population.

OBJECTIVE

Determine MCC incidence in the United States and project incident cases through the year 2025.

METHODS

Registry data were obtained from the SEER-18 Database, containing 6600 MCC cases. Age- and sex-adjusted projections were generated using US census data.

RESULTS

During 2000-2013, the number of reported solid cancer cases increased 15%, melanoma cases increased 57%, and MCC cases increased 95%. In 2013, the MCC incidence rate was 0.7 cases/100,000 person-years in the United States, corresponding to 2488 cases/year. MCC incidence increased exponentially with age, from 0.1 to 1.0 to 9.8 (per 100,000 person-years) among age groups 40-44 years, 60-64 years, and ≥85 years, respectively. Due to aging of the Baby Boomer generation, US MCC incident cases are predicted to climb to 2835 cases/year in 2020 and 3284 cases/year in 2025.

LIMITATIONS

We assumed that the age-adjusted incidence rate would stabilize, and thus, the number of incident cases we projected might be an underestimate.

CONCLUSION

An aging population is driving brisk increases in the number of new MCC cases in the United States. This growing impact combined with the rapidly evolving therapeutic landscape warrants expanded awareness of MCC diagnosis and management.

摘要

背景

默克尔细胞癌(MCC)的发病率正在上升,且与年龄高度相关,这与人口老龄化有关。

目的

确定美国的 MCC 发病率,并预测 2025 年的发病病例数。

方法

从包含 6600 例 MCC 病例的 SEER-18 数据库中获取登记数据。使用美国人口普查数据生成年龄和性别调整后的预测值。

结果

2000-2013 年间,报告的实体瘤病例数增加了 15%,黑色素瘤病例数增加了 57%,而 MCC 病例数增加了 95%。2013 年,美国 MCC 的发病率为 0.7 例/10 万人年,相当于每年 2488 例。MCC 发病率随年龄呈指数增长,在 40-44 岁、60-64 岁和≥85 岁的年龄组中,发病率分别为 0.1、1.0 和 9.8(每 10 万人年)。由于婴儿潮一代的老龄化,预计美国 MCC 的发病病例数将在 2020 年上升至 2835 例/年,在 2025 年上升至 3284 例/年。

局限性

我们假设年龄调整后的发病率将稳定,因此,我们预测的发病病例数可能低估了实际情况。

结论

人口老龄化正在推动美国新 MCC 病例数的快速增长。这种日益增长的影响,加上迅速发展的治疗领域,需要提高对 MCC 诊断和管理的认识。